Your browser doesn't support javascript.
loading
Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma.
Ye, Liangtao; Kriegl, Lydia; Reiter, Florian P; Munker, Stefan M; Itzel, Timo; Teufel, Andreas; Ziesch, Andreas; Török, Helga Paula; Kirchner, Thomas; Gerbes, Alexander L; Guba, Markus; Mayerle, Julia; De Toni, Enrico N.
Afiliação
  • Ye L; Department of Medicine II, Liver Centre Munich, University Hospital, LMU Munich, Germany.
  • Kriegl L; Digestive Medicine Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
  • Reiter FP; Institute of Pathology, University of Munich, Germany.
  • Munker SM; Department of Medicine II, Liver Centre Munich, University Hospital, LMU Munich, Germany.
  • Itzel T; Department of Medicine II, Liver Centre Munich, University Hospital, LMU Munich, Germany.
  • Teufel A; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Ziesch A; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Török HP; Department of Medicine II, Liver Centre Munich, University Hospital, LMU Munich, Germany.
  • Kirchner T; Department of Medicine II, Liver Centre Munich, University Hospital, LMU Munich, Germany.
  • Gerbes AL; Institute of Pathology, University of Munich, Germany.
  • Guba M; Department of Medicine II, Liver Centre Munich, University Hospital, LMU Munich, Germany.
  • Mayerle J; Department of General, Visceral and Transplantation Surgery, University Hospital, LMU Munich, Germany.
  • De Toni EN; Department of Medicine II, Liver Centre Munich, University Hospital, LMU Munich, Germany.
Clin Transl Gastroenterol ; 11(1): e00124, 2020 01.
Article em En | MEDLINE | ID: mdl-31990698
ABSTRACT

OBJECTIVES:

Hepatocellular carcinoma (HCC) is a leading cancer-related cause of death. Unfortunately, recurrence is common even after curative treatment of early-stage patients, and no adjuvant treatment has yet been established. Aberrant expression of OLFM4 in human cancers has been reported; yet, its specific function during tumor development remains poorly understood, and its role in HCC is unknown. The purpose of this study is to examine the prognostic significance of OLFM4 and its functional relevance in determining recurrence in patients with early-stage HCC.

METHODS:

Immunohistochemical staining to assess expression, cellular distribution, and prognostic significance of OLFM4 was performed in a tissue microarray comprising 157 HCC tissues and matched nontumor tissues. In addition, expression of OLFM4-coding mRNA was assessed in a separate patients' cohort. The findings were validated by in vitro functional studies using siRNA directed against OLFM4 to assess its effect on cell motility and proliferation.

RESULTS:

The fraction of HCC samples exhibiting positive OLFM4 staining was higher in comparison with that observed in hepatocytes from matched nontumor tissue (61% vs 39%). However, cytoplasmic-only staining for OLFM4 was associated with vascular invasion (P = 0.048), MMP-7 expression (P = 0.002), and poorer survival (P = 0.008). A multivariate analysis confirmed the independent significance of OLFM4 in determining patients' outcome (5-year survival [58.3% vs 17.3%; HR 2.135 {95% confidence interval 1.135-4.015}; P = 0.019]). Correspondingly, inhibition of OLFM4 by siRNA modulated the expression of MMP-7 and E-cadherin, causing inhibition of cell proliferation, motility, and migration.

DISCUSSION:

To the best of our knowledge, we provide the first report on the prognostic significance of OLFM4 in HCC and identify its mechanistic role as crucial mediator of MMP family protein and E-Cadherin in determining cell invasion and metastasis formation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Movimento Celular / Fator Estimulador de Colônias de Granulócitos / Carcinoma Hepatocelular / Proliferação de Células / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Movimento Celular / Fator Estimulador de Colônias de Granulócitos / Carcinoma Hepatocelular / Proliferação de Células / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article